Resultado de búsqueda
Bristol Myers Squibb is a company that develops and delivers innovative medicines for serious diseases. Learn about its latest cell therapy approval, lung cancer research, inclusion and diversity initiatives, and more.
- Patients & Caregivers
At Bristol Myers Squibb, we are committed to helping you get...
- Healthcare Providers
Bristol Myers Squibb provides information and resources to...
- Researchers
The Bristol Myers Squibb Foundation. People & Business...
- Investors
Forward-looking statements contained on this website should...
- Careers
At Bristol Myers Squibb, your work helps people prevail over...
- Our Medicines
Bristol Myers Squibb focuses on developing new medicines to...
- Contact Us
Contact Bristol Myers Squibb through our contact form,...
- Our Company
At Bristol Myers Squibb, we believe in the power of science...
- Patients & Caregivers
Obtenga más información sobre Bristol Myers Squibb y nuestra misión de descubrir, desarrollar y ofrecer medicamentos innovadores que ayuden a los pacientes en su lucha contra enfermedades graves.
Bristol-Myers Squibb, a menudo conocido como BMS, es una compañía farmacéutica, con sede en la ciudad de Nueva York. La empresa se formó en 1989, tras la fusión de sus predecesores de Bristol-Myers y la Corporación de Squibb.
Conozca más sobre Bristol-Myers Squibb y sobre nuestra misión para descubrir, desarrollar y proporcionar medicinas innovadoras a pacientes con enfermedades graves.
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
2 de feb. de 2023 · Bristol Myers Squibb posted revenues of $11.4 billion, a decrease of 5%, driven by recent LOE products (primarily Revlimid) and foreign exchange impacts, partially offset by in-line products (primarily Opdivo) and our new product portfolio (primarily Opdualag and Abecma).
21 de feb. de 2024 · Bristol Myers cambia de receta La compañía aspira a renovar su cartera de fármacos mediante adquisiciones de empresas y con inversiones en investigación y desarrollo que aceleren el ...
